BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7890725)

  • 21. Phosphorylation of the erythroid transcription factor GATA-1.
    Crossley M; Orkin SH
    J Biol Chem; 1994 Jun; 269(24):16589-96. PubMed ID: 8206977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deletion of a negatively acting sequence in a chimeric GATA-1 enhancer-long terminal repeat greatly increases retrovirally mediated erythroid expression.
    Testa A; Lotti F; Cairns L; Grande A; Ottolenghi S; Ferrari G; Ronchi A
    J Biol Chem; 2004 Mar; 279(11):10523-31. PubMed ID: 14701820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein-DNA interactions in the epsilon-globin gene silencer.
    Peters B; Merezhinskaya N; Diffley JF; Noguchi CT
    J Biol Chem; 1993 Feb; 268(5):3430-7. PubMed ID: 8429019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of connective tissue growth factor as a target of WT1 transcriptional regulation.
    Stanhope-Baker P; Williams BR
    J Biol Chem; 2000 Dec; 275(49):38139-50. PubMed ID: 10973960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcription factor GATA-1 regulates human HOXB2 gene expression in erythroid cells.
    Vieille-Grosjean I; Huber P
    J Biol Chem; 1995 Mar; 270(9):4544-50. PubMed ID: 7876223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Wilms' tumor suppressor Wt1 activates transcription of the erythropoietin receptor in hematopoietic progenitor cells.
    Kirschner KM; Hagen P; Hussels CS; Ballmaier M; Scholz H; Dame C
    FASEB J; 2008 Aug; 22(8):2690-701. PubMed ID: 18424770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of transcription of the human erythropoietin receptor gene by proteins binding to GATA-1 and Sp1 motifs.
    Chin K; Oda N; Shen K; Noguchi CT
    Nucleic Acids Res; 1995 Aug; 23(15):3041-9. PubMed ID: 7659529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GATA factors are essential for transcription of the survival gene E4bp4 and the viability response of interleukin-3 in Ba/F3 hematopoietic cells.
    Yu YL; Chiang YJ; Yen JJ
    J Biol Chem; 2002 Jul; 277(30):27144-53. PubMed ID: 12023274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wilms tumor and the WT1 gene.
    Lee SB; Haber DA
    Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression and functional role of GATA-2, NF-E2, and GATA-1 in normal adult hematopoiesis.
    Labbaye C; Valtieri M; Barberi T; Meccia E; Masella B; Pelosi E; Condorelli GL; Testa U; Peschle C
    J Clin Invest; 1995 May; 95(5):2346-58. PubMed ID: 7738198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential function of Wilms' tumor gene WT1 splice isoforms in transcriptional regulation.
    Hewitt SM; Fraizer GC; Wu YJ; Rauscher FJ; Saunders GF
    J Biol Chem; 1996 Apr; 271(15):8588-92. PubMed ID: 8621487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional regulation of the pyruvate kinase erythroid-specific promoter.
    Max-Audit I; Eleouet JF; Roméo PH
    J Biol Chem; 1993 Mar; 268(8):5431-7. PubMed ID: 8449904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
    Zhang X; Xing G; Saunders GF
    Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1.
    Zhang P; Behre G; Pan J; Iwama A; Wara-Aswapati N; Radomska HS; Auron PE; Tenen DG; Sun Z
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8705-10. PubMed ID: 10411939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of Wilms tumor WT1 splice variants on the insulin receptor promoter.
    Webster NJ; Kong Y; Sharma P; Haas M; Sukumar S; Seely BL
    Biochem Mol Med; 1997 Dec; 62(2):139-50. PubMed ID: 9441865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product.
    Dey BR; Sukhatme VP; Roberts AB; Sporn MB; Rauscher FJ; Kim SJ
    Mol Endocrinol; 1994 May; 8(5):595-602. PubMed ID: 8058069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A far upstream cis-element is required for Wilms' tumor-1 (WT1) gene expression in renal cell culture.
    Scholz H; Bossone SA; Cohen HT; Akella U; Strauss WM; Sukhatme VP
    J Biol Chem; 1997 Dec; 272(52):32836-46. PubMed ID: 9407061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCACC-binding or simian-virus-40-protein-1-binding proteins cooperate with human GATA-1 to direct erythroid-specific transcription and to mediate 5' hypersensitive site 2 sensitivity of a TATA-less promoter.
    Eleouet JF; Roméo PH
    Eur J Biochem; 1993 Mar; 212(3):763-70. PubMed ID: 8385011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of the transcriptional factor GATA-1 in regulation of expression of coproporphyrinogen oxidase in mouse erythroleukemia cells.
    Tanabe A; Furukawa T; Ogawa Y; Yamamoto M; Hayashi N; Tokunaga R; Taketani S
    Biochem Biophys Res Commun; 1997 Apr; 233(3):729-36. PubMed ID: 9168923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.
    Cook DM; Hinkes MT; Bernfield M; Rauscher FJ
    Oncogene; 1996 Oct; 13(8):1789-99. PubMed ID: 8895526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.